NEUROLITH installation: in the treatment of patients with Alzheimer’s disease, the »Rudolfinerhaus Privatklinik« in Vienna, Austria, relies on Transcranial Pulse Stimulation (TPS)


Throughout the world, more and more specialised medical centres are using Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system for the treatment of patients with Alzheimer’s disease. In June 2020, another NEUROLITH® system was installed successfully at the private hospital »Rudolfinerhaus Privatklinik« in Vienna, Austria, where it will be used under the medical direction of Dr Matthias Geisler. On-site training of the hospital’s treatment team was carried out by Dr Henning Lohse-Busch (Rheintalklinik, Bad Krozingen, Germany) who also played a decisive role in the development of TPS.

About TPS treatment
In 2018, Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«.

TPS can stimulate deep cerebral regions, reaching as much as 8 cm into the brain. Owing to the short duration of the TPS stimulation, tissue heating is avoided. The pulses applied to the treatment area thus develop their maximum clinical effectiveness. TPS treatment is performed through the closed skull. In studies, TPS treatment has been shown to significantly improve CERAD test performance and to reduce Beck’s depression index in patients with mild to moderate dementia.

2020 07 20 news NEUROLITH Installation Wien

From left to right: Werner Huber (RWZ Medical GmbH), Sebastian Müller (STORZ MEDICAL AG), Dr Matthias Geisler, Dr Henning Lohse-Busch

Including the NEUROLITH® installation at the »Rudolfinerhaus« in Vienna, there are now 16 treatment centres throughout the world that offer Transcranial Pulse Stimulation (TPS) for patients with Alzheimer’s disease. Further installations are being planned for this autumn.

Further information is available on our website.